{"altmetric_id":5975126,"counts":{"readers":{"mendeley":64,"citeulike":1,"connotea":1},"total":{"posts_count":15},"news":{"unique_users_count":15,"unique_users":["kusi_news","device_space","kplc_7_news","kceng12","tcmnet_com","bioportfolio","cnbc","digital_journal","bloomberg","yahoo_finance_usa","minyanville_finance","wtvm","mississippi_news_now","kait_tv","arizona_daily_star"],"posts_count":15}},"citation":{"authors":["Drusenheimer N","Wulf G","Nolte J","Lee JH","Dev A","Dressel R","Gromoll J","Schmidtke J","Engel W","Nayernia K"],"first_seen_on":"2016-02-23T17:34:56+00:00","issns":[""],"last_mentioned_on":1456249348,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17566262"],"pmid":"17566262","subjects":["reproductivemedicine"],"title":"Putative human male germ cells from bone marrow stem cells","type":"article","volume":"63","mendeley_url":"http:\/\/www.mendeley.com\/research\/putative-human-male-germ-cells-bone-marrow-stem-cells-1"},"altmetric_score":{"score":115,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":115},"context_for_score":null},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":4,"Student  > Ph. D. Student":2,"Student  > Postgraduate":3,"Student  > Master":4,"Lecturer":1},"by_discipline":{"Medicine and Dentistry":5,"Chemistry":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":9}}},"geo":{"mendeley":{"SI":1}}},"posts":{"news":[{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568585207&p=1pl&v=1&x=HX99NldfER31vXf5wCAbMQ","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:59:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX --(BUSINESS WIRE) Creative Medical Technologies, Inc.","author":{"name":"KUSI News","url":"http:\/\/www.kusi.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/663\/normal\/Screen_Shot_2016-01-26_at_13.26.05.png?1453815145"}},{"title":"Creative Medical Technologies Licenses Patient Specific Adult Stem Cell Therapy For Male Infertility","url":"http:\/\/www.devicespace.com\/news_story.aspx?StoryID=409690&full=1","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126],"posted_on":"2016-02-23T00:00:00+00:00","summary":"PHOENIX--(BUSINESS WIRE)--Creative Medical Technologies, Inc. (CMT) announced today the signing of a license agreement with LA BioMed granting exclusive rights for United States patent application #14\/508763, covering the use of stem cells for\u2026","author":{"name":"Device Space","url":"http:\/\/www.devicespace.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/840\/normal\/Screen_Shot_2016-02-02_at_15.36.30.png?1454427403"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568621398&p=1pl&v=1&x=sQEfsdYDdiYafA_GPZi8Ow","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:59:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX --(BUSINESS WIRE) Creative Medical Technologies, Inc.","author":{"name":"KPLC 7 News","url":"http:\/\/www.kplctv.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/641\/normal\/Screen_Shot_2016-01-26_at_11.30.17.png?1453807834"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568623991&p=1pl&v=1&x=dCeKzZ5jatchZNYd3SVtyg","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:59:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX --(BUSINESS WIRE) Creative Medical Technologies, Inc.","author":{"name":"KCENG12","url":"http:\/\/www.kcentv.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/642\/normal\/Screen_Shot_2016-01-26_at_11.32.50.png?1453808008"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25569002157&p=1pl&v=1&x=s6TjK5YqFR8WkSMDLl37JA","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T17:42:28+00:00","summary":"] Creative Medical Technologies, Inc. (CMT) announced today the signing of a license agreement with LA BioMed granting exclusive rights for United States patent application #14\/508763, covering the use of stem cells for treatment of male infertility.","author":{"name":"TMCnet.com","url":"http:\/\/www.tmcnet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/169\/normal\/Screen_Shot_2014-10-01_at_14.45.46.png?1412171168"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568441140&p=1pl&v=1&x=Q8y99VfVec9I_prPvve_2w","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:48:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications Creative Medical Technologies, Inc.","author":{"name":"Bioportfolio","url":"http:\/\/www.bioportfolio.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/821\/normal\/Screen_Shot_2015-12-11_at_16.36.54.png?1449851849"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568448397&p=1pl&v=1&x=e_HFo5n70hdOXhi9WNOUAA","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:48:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX--(BUSINESS WIRE)-- Creative Medical Technologies, Inc.","author":{"name":"CNBC","url":"http:\/\/www.cnbc.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/411\/normal\/Screen_Shot_2016-01-12_at_14.43.08.png?1452609805"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility - Press Release","url":"http:\/\/ct.moreover.com\/?a=25568494992&p=1pl&v=1&x=rZi8-zDZ_XhMOoSrN-GzTw","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:53:44+00:00","summary":"\u0001PHOENIX--(Business Wire)--Creative Medical Technologies, Inc. (CMT) announced today the signing of a license agreement with LA BioMed granting exclusive rights for United States patent application #14\/508763, covering the use of stem cells for\u2026","author":{"name":"Digital Journal","url":"http:\/\/www.digitaljournal.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/223\/normal\/image.png?1371424893"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568496033&p=1pl&v=1&x=x5Yy7sDjJZ81SfOqoiCO3Q","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:53:50+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX--(BUSINESS WIRE)--Feb.","author":{"name":"Bloomberg","url":"http:\/\/www.bloomberg.com\/europe","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/659\/normal\/Screen_Shot_2016-01-26_at_12.11.18.png?1453810324"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568552972&p=1pl&v=1&x=Vy0aeKlHNhF6fKQaRYyKbQ","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:48:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications Creative Medical Technologies 10 minutes ago Done PHOENIX--(BUSINESS WIRE)-- Creative Medical Technologies, Inc.","author":{"name":"Yahoo! Finance USA","url":"http:\/\/finance.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/620\/normal\/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568521065&p=1pl&v=1&x=roSwZNknzkG2vs-l2Irg8Q","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:48:00+00:00","summary":"Creative Medical Technologies, a clinical stage biotech company, licenses patent for stem cell treatment of male infertility from LA BioMed.","author":{"name":"Minyanville: Finance ","url":"http:\/\/finance.minyanville.com\/minyanville","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/637\/normal\/Screen_Shot_2016-02-02_at_16.44.51.png?1454431502"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568567323&p=1pl&v=1&x=1qVZcgQlwW60bAxdWlvE-w","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:59:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX --(BUSINESS WIRE) Creative Medical Technologies, Inc.","author":{"name":"WTVM","url":"http:\/\/www.wtvm.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/646\/normal\/Screen_Shot_2016-02-02_at_14.58.13.png?1454425111"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568614155&p=1pl&v=1&x=oUvK3u39s8NCN-vIDWoMjQ","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:59:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX --(BUSINESS WIRE) Creative Medical Technologies, Inc.","author":{"name":"Mississippi News Now ","url":"http:\/\/www.msnewsnow.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/649\/normal\/Screen_Shot_2016-01-26_at_11.57.00.png?1453809440"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25568614743&p=1pl&v=1&x=xlm3fcnpG5_6_tibc2Xo7w","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T16:59:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX --(BUSINESS WIRE) Creative Medical Technologies, Inc.","author":{"name":"KAIT-TV","url":"http:\/\/www.kait8.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/672\/normal\/Screen_Shot_2016-01-26_at_14.02.53.png?1453817085"}},{"title":"Creative Medical Technologies Licenses Patient-Specific Adult Stem Cell Therapy for Male Infertility","url":"http:\/\/ct.moreover.com\/?a=25569336305&p=1pl&v=1&x=F_h-PfglH6PdvmP6-pD9jg","license":"public","citation_ids":[5975124,3982631,4840887,2545318,5975125,5975126,5975172,5975173,5975174],"posted_on":"2016-02-23T11:48:00+00:00","summary":"Clinical Stage Adult Stem Cell Company Expands Portfolio of Clinical Indications PHOENIX--(BUSINESS WIRE)--Creative Medical Technologies, Inc.","author":{"name":"Arizona Daily Star","url":"http:\/\/tucson.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/270\/normal\/Screen_Shot_2016-01-12_at_14.20.34.png?1452608450"}}]}}